Latest Orasure Technologies (OSUR) Headlines Uptrend

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Orasure Technologies (OSUR) Headlines

Uptrend Call Working As OraSure Technologies Stock Rises 19.2% (OSUR)
Comtex SmarTrend(R) - 1 hr 6 mins ago
SmarTrend identified an Uptrend for OraSure Technologies (NASDAQ:OSUR) on February 18th, 2014 at $6.74. In approximately 3 weeks, OraSure Technologies has returned 19.23% as of today's recent price of $8.03.

Regulatory Approvals, Pricing of Public Offering, Stock Price Movements, and Financial Reports - Analyst Notes on Arrowhead, ANI, OraSure, Rigel, and Foundation Medicine
PR Newswire - Mon Mar 10, 11:30AM CDT
Today, Analysts Review released its analysts' notes regarding Arrowhead Research Corp. (NASDAQ: ARWR), ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), OraSure Technologies, Inc. (NASDAQ: OSUR), Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), and Foundation Medicine, Inc. (NASDAQ: FMI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

3 Ways You Can Be a Better Health-Care Investor Than Warren Buffett
Sean Williams, The Motley Fool - Motley Fool - Sun Mar 09, 1:03PM CDT
Behind only three other people on this planet -- Bill Gates, Carlos Slim, and Amancio Ortega -- stands Warren Buffett with $58.2 billion in accumulated wealth, according to Forbes ' latest rankings of the world's richest people. Buffett, perhaps...

Why OraSure Technologies, Inc. Shares Jumped
Sean Williams, The Motley Fool - Motley Fool - Wed Mar 05, 4:07PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of OraSure Technologies , a marketer of...

OraSure Technologies to Present at the Cowen & Company 34th Annual Health Care Conference
GlobeNewswire - Wed Feb 26, 5:00AM CST
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Cowen & Co. 34 Annual Health Care Conference in Boston, Massachusetts. The conference will be simultaneously webcast over the Internet.

OraSure Technologies to Present at the Raymond James 35th Annual Institutional Investors Conference
GlobeNewswire - Mon Feb 24, 5:12AM CST
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Raymond James 35 Annual Institutional Investors Conference in Orlando, Florida. The conference will be simultaneously webcast over the Internet.

Fusion Antibodies Announces Collaboration with Pepscan to offer Precision Epitope Mapping
PRWeb - Mon Feb 24, 2:08AM CST
UK based contract research organisation Fusion Antibodies and Dutch based biotechnology company Pepscan, a leading provider of epitope mapping services, have today announced a partnership to offer Pepscan's Precision Epitope Mapping platform to Fusion Antibodies clients. The partnership will have great benefits for Fusion Antibodies clients as it will offer them an integrated end-to-end solution for the pre-clinical development of antibodies. Fusion Antibodies can now not only provide Antibody Engineering, Humanization and development of high yielding stable cell lines but a range of high quality characterisation studies through their expert partners.

OraSure Technologies to Present at the 2014 Citi Global Healthcare Conference
GlobeNewswire - Thu Feb 20, 5:00AM CST
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the 2014 Citi Global Healthcare Conference in New York City. The conference will be simultaneously webcast over the Internet.

OraSure Technologies (OSUR) Jumps: Stock Up 10.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 7:51AM CST
OraSure Technologies, Inc. was a big mover last session, as its shares rose over 10% on the day.

Biotech Winners: Pernix, Myriad, Repros, OraSure
David Williamson and Max Macaluso, The Motley Fool - Motley Fool - Thu Feb 06, 7:40PM CST
In this video from Thursday's Market Checkup , Motley Fool health-care analysts David Williamson and Max Macaluso dive into the biggest stories impacting health-care investors on the market today. In this segment, a look at some big winners during...

Why OraSure Technologies, Inc. Shares Popped
Alex Planes, The Motley Fool - Motley Fool - Thu Feb 06, 12:11PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of OraSure Technologies, have gained 10%...

OraSure Technologies to Present at the Leerink Swan Global Healthcare Conference
GlobeNewswire - Thu Feb 06, 5:00AM CST
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Ronald Spair, Chief Operating Officer & Chief Financial Officer, will speak to the investment community at the Leerink Swan Global Healthcare Conference in New York City. The conference will be simultaneously webcast over the Internet.

OraSure Announces Record Full-Year and Quarterly Revenues
GlobeNewswire - Wed Feb 05, 3:00PM CST
OraSure Technologies, Inc. (Nasdaq:OSUR), a market leader in oral fluid diagnostics, today announced its consolidated financial results for the full-year and fourth quarter of 2013.

OraSure Technologies Announces 2014 Annual Meeting Date
GlobeNewswire - Tue Jan 28, 5:00AM CST
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that its 2014 Annual Meeting of Stockholders is scheduled to be held on Thursday, May 22, 2014. Further details regarding the meeting will be provided at a later date.

Janssen Announces New Group Targeting Unmet Global Health Needs
PR Newswire - Wed Jan 22, 7:15AM CST
Janssen, the pharmaceutical companies of Johnson & Johnson, today announced the formation of Janssen Global Public Health (Janssen GPH), an important new group unifying Janssen's commitment to research, develop, and deliver transformational medicines to address the world's greatest unmet public health needs. Janssen GPH will align the company's groundbreaking science and innovative access models under a single entity to drive better health outcomes, improve quality of life for patients, and sustainably advance health for people all over the world.

OraSure Technologies Earnings Conference Call Invitation
GlobeNewswire - Mon Jan 20, 5:00AM CST
OraSure Technologies, Inc. (Nasdaq:OSUR) has scheduled its regular earnings conference call covering 2013 fourth quarter and full year financial results and certain 2014 financial guidance for 5:00 pm ET (2:00 pm PT) Wednesday, February 5, 2014. An update on certain business developments will also be provided.

10 Countries With the Shortest Life Expectancy
Sean Williams, The Motley Fool - Motley Fool - Sat Jan 11, 10:16AM CST
Yesterday, we examined the envy of the rest of the world: 10 countries with the longest life expectancy . Today, we're going to flip the table and examine the other point of view: 10 countries with the shortest life expectancy. As the World Health...

2013 Report on the In-Vitro Diagnostic Substance Manufacturing Industry Features Players such as Hologic, Inc. and Quidel Corporation
M2 - Tue Jan 07, 10:17AM CST
Research and Markets (http://www.researchandmarkets.com/research/7dvwjc/invitro) has announced the addition of Supplier Relations US, LLC's new report "In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [2013 Q4 Edition]" to their offering. The industry's revenue for the year 2012 was reported at $12.6 billion USD, with an estimated gross profit of 43.66%. The industry used a projected 64 percent of its full production capacity in 2012. The industry could have increased its total shipment value to $19.6 billion USD under full production capacity. This industry did not have direct foreign trade statistics. The report nevertheless depicted relevant foreign trade data from a higher level NAICS industry or industry group. This 2013 year-end publication of In-Vitro Diagnostic Substance Manufacturing Industry report is the comprehensive market research guide for the industry. It contains the latest information on the industry's key financial data, competitive landscape, cost and pricing, and trends during the current environment, including the output and shipment changes over the past months. At 173 pages with over 150 charts and tables, the report covers topics such as current macroeconomic trends, granular product data, global trade, channel mix, government demand, and labor structure. It uses over a decade of historical data to forecast industry trends through 2017 on the domestic market, global market and overseas growth opportunities. This current report contains shipment data, inventory levels, international trade volume, and industry specific price indices available through September 2013. Industry analysts and Fortune 500 customers rely on this quarterly report to make accurate forecasts and planning in today's uncertain economy. Companies Mentioned: - Abaxis Inc. - Affymetrix, Inc. - Alere - Amag Pharmaceuticals Inc. - ARCA biopharma - Bracco Diagnostic Inc. - Celsis In Vitro Technologies - EXACT Sciences Corporation - General Electric Company - Hologic, Inc. - IDEXX Laboratories, Inc. - Johnson & Johnson - Monogram Biosciences, Inc. - Myriad Genetics, Inc. - OraSure Technologies, Inc. - Peregrine Pharmaceuticals, Inc. - Quidel Corporation - Radient Pharmaceuticals Corporation For more information visit http://www.researchandmarkets.com/research/7dvwjc/invitro Source: Supplier Relations US, LLC About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

OraSure Technologies Addresses FDA Warning Letter Received by Its Subsidiary DNA Genotek
GlobeNewswire - Tue Jan 07, 8:52AM CST
OraSure Technologies, Inc. (Nasdaq:OSUR) announced that its molecular collection systems subsidiary, DNA Genotek, received a warning letter from the U.S. Food and Drug Administration (FDA) which the FDA posted today on its website. The warning letter primarily focuses on DNA Genotek's response to two observations issued by the FDA on Form 483 as a result of a routine inspection of DNA Genotek's Ottawa, Canada facilities in September 2013.

OraSure Technologies Inc. (OSUR) Stock Research Links

OSUR Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stowers Brings a Transformation CTO Into Its Lab

Updated Category News Views 125

Data Has Become Lab Infrastructure Microscopes may get the glory, but the plumbing behind modern biology is increasingly digital, sprawling and unforgiving. That is why Stowers Institute for Medical Research appointing Brandon Mayer as vice president and chief technology officer on November 19, 2026, deserves more attention than the usual executive-shuffle treatment. This...

Continue Reading
Lecanemab's Alpha-Syn Signal Deserves a Cooler Head

Updated Category News Views 108

Mixed pathology is where Alzheimer's investing gets uncomfortably real, and this new lecanemab readout is a decent reminder that a drug can show promise without settling the argument. Eisai and Biogen presented a Clarity AD cerebrospinal-fluid substudy at CTAD 2026 examining people with early Alzheimer's disease who also tested positive for alpha-synuclein pathology. The...

Continue Reading
StoneX Selloff Puts Earnings Quality Under a Harsh Lens

Updated Category News Views 111

A revenue beat can turn downright useless when the profit line springs a leak. StoneX Group delivered operating revenue above expectations and record full-year results, then watched investors hammer the stock after fiscal fourth-quarter diluted earnings per share landed at $0.66. That was $0.15 below the roughly $0.81 consensus cited in the notice, and other estimates...

Continue Reading
Veterinary Biologics Growth Has a Valuable Catch Ahead

Updated Category News Views 20

Pet allergies and livestock disease are hardly glamorous, yet they are becoming a durable spending lane. The veterinary biologics market is projected to rise from $2.85 billion in 2026 to $3.69 billion by 2031, a 5.3% compound annual growth rate. That is not the kind of growth figure that makes anyone pound the table, and frankly it should not. It is the sort that can...

Continue Reading
PinnacleQM Makes Its Enterprise Case More Visible

Updated Category News Views 118

Six pages were never going to carry the weight of a complicated enterprise pitch. PinnacleQM has rebuilt its public face from a basic brochure into a library of more than 50 pages, putting its quality engineering, testing, automation and AI assurance work in clearer view for Australian technology and business buyers. This is not the sort of announcement that changes a...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 83

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
Duetti, CesiumAstro, and a Busy NYSE Capital Morning

Updated Category News Views 58

Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....

Continue Reading
SOCi's MCP Push Makes Context the Product Moat Bigger

Updated Category News Views 135

Software agents without decent business context are just eager interns with access to the keyboard. SOCi’s November 19, 2026 announcement gets at that unglamorous truth: the company has made its Model Context Protocol server generally available and says its context layer now connects with more than 140 integrations. It is not a flashy new chatbot stunt. It is a bid to...

Continue Reading
Epilepsy Campaign Puts Patient Voices Before Investors

Updated Category News Views 0

An epilepsy diagnosis can turn ordinary family routines into a maze overnight, which is why awareness work deserves more than the usual polite nod and a colored ribbon. Mediaplanet's national Epilepsy Awareness campaign, launched November 20, 2026, brings the subject into a USA TODAY print insert and related digital coverage during Epilepsy Awareness Month. That reach...

Continue Reading
L’Oréal’s Women of Worth Shows Why Brand Patience Matters

Updated Category News Views 138

Twenty-one years is a long time to keep a corporate promise from turning into wallpaper. L’Oréal Paris gathered its 2026 Women of Worth class at the Ebell in Los Angeles on November 18, recognizing 10 nonprofit leaders working on problems that do not yield to a glitzy evening or a tidy slogan. That distinction matters. Cancer survivorship, trafficking prevention,...

Continue Reading

Top 5 Most Recently Viewed Articles

MAGNA-TILES Unveils Exciting Rail Racers To Transform Play

Updated Category News Views 562

MAGNA-TILES Innovates Play with Rail Racers Launch First Fan-Made Invention Reimagines Ball Runs and Takes Magnetic Building to the Next Level MAGNA-TILES, America’s favorite magnetic building toy brand, has introduced an exciting innovation—the Rail Racers. This remarkable new product debuted at the American International Toy Fair, showcasing the creativity of the...

Continue Reading
Discover DDB Miner’s Innovative Approach to Bitcoin Mining

Updated Category News Views 167

Unlocking the Future of Bitcoin Mining DDB Miner, a forward-thinking Bitcoin mining entity, is making significant strides in the cryptocurrency industry. By emphasizing low-cost and efficient operations, DDB Miner is set on a path to redefine how Bitcoin is mined. Their latest operational update sheds light on impressive developments and ambitious plans that promise to...

Continue Reading
Warren Buffett Plans Charitable Giving with New CEO Transition

Updated Category News Views 217

Warren Buffett Speeds Up Charitable Contributions Warren Buffett recently announced that he will accelerate the distribution of his vast fortune, amounting to $149 billion, to his children's charitable foundations. This strategic decision aligns with the responsibilities he feels as a father, recognizing the increasing ages of his children. The Transition to Greg Abel As...

Continue Reading
Understanding the DeFi Technologies Class Action and Its Impact

Updated Category News Views 238

DeFi Technologies Class Action Explained Robbins LLP recently brought to light a class action lawsuit on behalf of investors who bought or acquired shares of DeFi Technologies Inc. (NASDAQ: DEFT). This action covers a specific timeframe, reflecting concerns over the company’s alleged misrepresentation of its business prospects. Investors seeking clarity on this...

Continue Reading
Alibaba's Robotics Innovation: Shaping the Future of AI Tech

Updated Category News Views 199

Alibaba's Bold Move into Robotics Alibaba Group (NYSE: BABA) has embarked on an exciting new venture by launching its own robotics team to compete in the rapidly advancing field of AI-powered physical products. This initiative reflects Alibaba's commitment to integrating artificial intelligence into everyday applications, transforming how technology interacts with the...

Continue Reading